Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 12828

Original article / research
Year : 2017 | Month : October | Volume : 11 | Issue : 10 | Page : PC01 - PC04

Role of Aspirin in Patients with Bladder Cancer Receiving Intravesical Bacillus Calmette-Guerin: A Prospective, Observational Study

Rupesh Gupta, Ranjit KumarDas, Sweta Gupta, Arpan Choudhary, Supriya Basu, Parthav PDeb, Ranjan K Dey

1. Senior Resident, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 2. Professor and Head, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 3. Junior Resident, Department of Obstetrics and Gynaecology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 4. Senior Resident, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 5. Professor, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 6. Senior Resident, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India. 7. Associate Professor, Department of Urology, R G Kar Medical College and Hospital, Kolkata, West Bengal, India.

Correspondence Address :
Dr. Ranjit Kumar Das,
7th Floor, Emergency Building, Department of Urology, 1, Khudiram Bosesarani,
R G Kar Medical College and Hospital, Kolkata-700004, West Bengal, India.
E-mail: drdasrk@rediffmail.com

Abstract

Introduction: High-Risk Non-Muscle Invasive Bladder Cancers (HR NMIBC) are prone to recur and progress even with intravesical Bacillus Calmette-Guerin (BCG) therapy.

Aim: To investigate the role of aspirin in prevention of early recurrence and progression in patients with HR NMIBC receiving intravesical BCG.

Materials and Methods: This was a prospective, single-centre, observational study that included patients with HR NMIBC {Ta, T1 or Carcinoma in situ (CIS)} from February 2015 to January 2017. Patients were screened for eligibility based on clinical, radiological and risk factor profile assessment, history of treatment with aspirin and medical records. Eligible patients were grouped into Group 1 and Group 2 based on aspirin (for minimum of three months) or non-aspirin consumption respectively. Both groups received similar induction, maintenance and intravesical BCG therapy; according to Southwest Oncology Group (SWOG) protocol. Follow up cystoscopy was done every three monthly for up to two years.

Results: A total of 152 patients were screened and 103 patients were included in the study (Group 1, n=15; Group 2, n=88). Binary progression analysis revealed that focality was the only significant predictor variable for the recurrence (OR, 5.064; p=0.001). Aspirin intake was not related to stage (p=0.595), grade (p=0.558), recurrence (p=0.508) and progression (p=0.621) of the tumour. Kaplan-Meier analysis showed that 12-month recurrence (64.2% versus 64.7%, p=0.566) and progression free survival rate (66.7% versus 57.3%, p=0.640) were same in both groups.

Conclusion: Results showed that aspirin does not affect the recurrence and progression of HR NMIBC patients receiving BCG therapy.

Keywords

Acetylsalicylic acid, Nonsteroidal anti-inflammatory drugs, Progression, Recurrence

How to cite this article :

Rupesh Gupta, Ranjit KumarDas, Sweta Gupta, Arpan Choudhary, Supriya Basu, Parthav PDeb, et al.. ROLE OF ASPIRIN IN PATIENTS WITH BLADDER CANCER RECEIVING INTRAVESICAL BACILLUS CALMETTE-GUERIN: A PROSPECTIVE, OBSERVATIONAL STUDY. Journal of Clinical and Diagnostic Research [serial online] 2017 October [cited: 2017 Oct 23 ]; 11:PC01-PC04. Available from
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=October&volume=11&issue=10&page=PC01-PC04&id=10690

DOI and Others

DOI: 10.7860/JCDR/2017/31588.10690

Date of Submission: Jul 14, 2017
Date of Peer Review: Aug 03, 2017
Date of Acceptance: Aug 30, 2017
Date of Publishing: Oct 01, 2017

FINANCIAL OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com